Started in 1978, Biogen is a number one world-wide biotechnology corporation which includes pioneered several breakthrough improvements such as a broad portfolio of medicines to deal with multiple sclerosis, the first accepted therapy for spinal muscular atrophy, two co-made treatment options to address a defining pathology of Alzheimer’s sicknes